Aarti Pharmalabs Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Consistent revenue growth: Aarti Pharmalabs has shown steady revenue increases over the past three quarters, indicating strong demand for its products.
Improved profit margins: The latest quarter saw an uptick in profit margins, reflecting better cost management and operational efficiency.
Strong R&D investments: Increased spending on research and development suggests future product innovation and market expansion potential.

NEGATIVES

Rising raw material costs: Escalating input costs have pressured profit margins, a trend noticed in previous quarters as well.
Regulatory challenges: Compliance with stringent industry regulations has increased, potentially hindering growth and operational flexibility.
Fluctuating export demand: A decrease in international orders during the latest quarter raises concerns about market stability and diversification.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	458.36	439.80	448.69	505.77	555.49	458.03	537.78	563.78	386.19
Expenses	373.49	351.81	353.01	388.25	459.03	364.35	409.17	418.15	290.95
Operating Profit	84.86	87.99	95.68	117.51	96.46	93.67	128.61	145.63	95.24
Other Income	0.48	0.98	1.39	2.03	2.22	4.48	5.03	-1.61	1.60
Interest	4.17	3.89	4.48	4.68	4.83	5.51	9.97	6.58	6.79
Depreciation	17.20	18.14	18.77	19.12	20.17	20.88	23.04	22.82	22.79
Profit Before Tax	63.98	66.95	73.82	95.75	73.68	71.77	100.63	114.62	65.45
Tax	16.88	15.14	21.05	30.50	18.22	17.14	26.64	26.28	15.95
Net Profit	47.09	51.80	52.76	65.25	55.45	54.62	73.99	88.34	49.50
Eps in Rs	5.20	5.72	5.82	7.20	6.12	6.03	8.16	9.75	5.46